Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 9
2018 84
2019 109
2020 144
2021 135
2022 89
2023 109
2024 35

Text availability

Article attribute

Article type

Publication date

Search Results

642 results

Results by year

Filters applied: . Clear all
Page 1
Derazantinib alone and with atezolizumab in metastatic urothelial carcinoma with activating FGFR aberrations.
Necchi A, Ramlau R, Falcón González A, Chaudhry A, Todenhöfer T, Tahbaz R, Fontana E, Giannatempo P, Deville JL, Pouessel D, Yoon S, Powles T, Bernat M, Häckl M, Marszewska M, McKernan P, Saulay M, Scaleia F, Engelhardt M, Loriot Y, Siefker-Radtke A, De Santis M. Necchi A, et al. JNCI Cancer Spectr. 2024 Apr 16:pkae030. doi: 10.1093/jncics/pkae030. Online ahead of print. JNCI Cancer Spectr. 2024. PMID: 38627238
Severe housing cost burden and premature mortality from cancer.
Lawrence WR, Freedman ND, McGee-Avila JK, Mason L, Chen Y, Ewing AP, Shiels MS. Lawrence WR, et al. JNCI Cancer Spectr. 2024 Feb 19:pkae011. doi: 10.1093/jncics/pkae011. Online ahead of print. JNCI Cancer Spectr. 2024. PMID: 38372706
Internet-based cognitive rehabilitation for working cancer survivors: results of a multicenter randomized controlled trial.
Klaver KM, Duijts SFA, Geusgens CAV, Kieffer JM, Agelink van Rentergem J, Hendriks MP, Nuver J, Marsman HA, Poppema BJ, Oostergo T, Doeksen A, Aarts MJB, Ponds RWHM, van der Beek AJ, Schagen SB. Klaver KM, et al. JNCI Cancer Spectr. 2024 Jan 4;8(1):pkad110. doi: 10.1093/jncics/pkad110. JNCI Cancer Spectr. 2024. PMID: 38273712 Free PMC article. Clinical Trial.
Risk of adverse birth outcomes after adolescent and young adult cancer.
Anderson C, Baggett CD, Engel SM, Getahun D, Cannizzaro NT, Mitra S, Meernik C, Moy LM, Laurent CA, Zhou X, Xu L, Kwan ML, Wood WA, Luke B, Chao CR, Kushi LH, Nichols HB. Anderson C, et al. JNCI Cancer Spectr. 2024 Jan 4;8(1):pkad106. doi: 10.1093/jncics/pkad106. JNCI Cancer Spectr. 2024. PMID: 38127994 Free PMC article.
Low RNA disruption during neoadjuvant chemotherapy predicts pathologic complete response absence in patients with breast cancer.
Cazzaniga ME, Ademuyiwa F, Petit T, Tio J, Generali D, Ciruelos EM, Califaretti N, Poirier B, Ardizzoia A, Hoenig A, Lex B, Mouret-Reynier MA, Giesecke D, Isambert N, Masetti R, Pitre L, Wrobel D, Augereau P, Milani M, Rask S, Solbach C, Pritzker L, Noubir S, Parissenti A, Trudeau ME. Cazzaniga ME, et al. JNCI Cancer Spectr. 2024 Jan 4;8(1):pkad107. doi: 10.1093/jncics/pkad107. JNCI Cancer Spectr. 2024. PMID: 38113421 Free PMC article.
Phase I and II randomized clinical trial of an oral therapeutic vaccine targeting human papillomavirus for treatment of cervical intraepithelial neoplasia 2 and 3.
Kawana K, Kobayashi O, Ikeda Y, Yahata H, Iwata T, Satoh T, Akiyama A, Maeda D, Hori-Hirose Y, Uemura Y, Nakayama-Hosoya K, Katoh K, Katoh Y, Nakajima T, Taguchi A, Komatsu A, Asai-Sato M, Tomita N, Kato K, Aoki D, Igimi S, Kawana-Tachikawa A, Schust DJ. Kawana K, et al. JNCI Cancer Spectr. 2023 Oct 31;7(6):pkad101. doi: 10.1093/jncics/pkad101. JNCI Cancer Spectr. 2023. PMID: 38001029 Free PMC article. Clinical Trial.
The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer.
Lammers SWM, Geurts SME, van Hellemond IEG, Swinkels ACP, Smorenburg CH, van der Sangen MJC, Kroep JR, de Graaf H, Honkoop AH, Erdkamp FLG, de Roos WK, Linn SC, Imholz ALT, Smidt ML, Vriens IJH, Tjan-Heijnen VCG. Lammers SWM, et al. JNCI Cancer Spectr. 2023 Oct 31;7(6):pkad092. doi: 10.1093/jncics/pkad092. JNCI Cancer Spectr. 2023. PMID: 37991939 Free PMC article. Clinical Trial.
Zillow MD: Do housing prices predict cancer survival?
Dinan MA, Wheeler SB. Dinan MA, et al. JNCI Cancer Spectr. 2023 Oct 31;7(6):pkad086. doi: 10.1093/jncics/pkad086. JNCI Cancer Spectr. 2023. PMID: 37965909 Free PMC article. No abstract available.
Accuracy of oncologists' estimates of expected survival time in advanced cancer.
Nahm SH, Martin AJ, Clayton JM, Grimison P, Moth EB, Pavlakis N, Sjoquist K, Smith-Uffen MES, Tognela A, Vasista A, Stockler MR, Kiely BE. Nahm SH, et al. JNCI Cancer Spectr. 2023 Oct 31;7(6):pkad094. doi: 10.1093/jncics/pkad094. JNCI Cancer Spectr. 2023. PMID: 37963058 Free PMC article.
Systematic symptom management in the IMPACT Consortium: rationale and design for 3 effectiveness-implementation trials.
Smith AW, DiMartino L, Garcia SF, Mitchell SA, Ruddy KJ, Smith JD, Wong SL, Cahue S, Cella D, Jensen RE, Hassett MJ, Hodgdon C, Kroner B, Osarogiagbon RU, Popovic J, Richardson K, Schrag D, Cheville AL; IMPACT Consortium. Smith AW, et al. JNCI Cancer Spectr. 2023 Oct 31;7(6):pkad073. doi: 10.1093/jncics/pkad073. JNCI Cancer Spectr. 2023. PMID: 37930033 Free PMC article.
Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types.
Naderi E, Aguado-Barrera ME, Schack LMH, Dorling L, Rattay T, Fachal L, Summersgill H, Martínez-Calvo L, Welsh C, Dudding T, Odding Y, Varela-Pazos A, Jena R, Thomson DJ, Steenbakkers RJHM, Dennis J, Lobato-Busto R, Alsner J, Ness A, Nutting C, Gómez-Caamaño A, Eriksen JG, Thomas SJ, Bates AM, Webb AJ, Choudhury A, Rosenstein BS, Taboada-Valladares B, Herskind C, Azria D, Dearnaley DP, de Ruysscher D, Sperk E, Hall E, Stobart H, Chang-Claude J, De Ruyck K, Veldeman L, Altabas M, De Santis MC, Farcy-Jacquet MP, Veldwijk MR, Sydes MR, Parliament M, Usmani N, Burnet NG, Seibold P, Symonds RP, Elliott RM, Bultijnck R, Gutiérrez-Enríquez S, Mollà M, Gulliford SL, Green S, Rancati T, Reyes V, Carballo A, Peleteiro P, Sosa-Fajardo P, Parker C, Fonteyne V, Johnson K, Lambrecht M, Vanneste B, Valdagni R, Giraldo A, Ramos M, Diergaarde B, Liu G, Leal SM, Chua MLK, Pring M, Overgaard J, Cascallar-Caneda LM, Duprez F, Talbot CJ, Barnett GC, Dunning AM, Vega A, Andreassen CN, Langendijk JA, West CML, Alizadeh BZ, Kerns SL; Radiogenomics Consortium. Naderi E, et al. JNCI Cancer Spectr. 2023 Oct 31;7(6):pkad088. doi: 10.1093/jncics/pkad088. JNCI Cancer Spectr. 2023. PMID: 37862240 Free PMC article.
Individual-level home values and cancer mortality in a statewide registry.
Zhu A, Rhodes S, Dong W, Rose J, Cullen J, Miller DB, Spratt DE, Ponsky L, Shoag D, Trapl E, Schumacher F, Penukonda S, Brant A, Strasser MO, Koroukian SM, Markt S, Shoag JE. Zhu A, et al. JNCI Cancer Spectr. 2023 Oct 31;7(6):pkad076. doi: 10.1093/jncics/pkad076. JNCI Cancer Spectr. 2023. PMID: 37796836 Free PMC article.
Radium-223 in metastatic castration-resistant prostate cancer: whole-body diffusion-weighted magnetic resonance imaging scanning to assess response.
Parker C, Tunariu N, Tovey H, Alonzi R, Blackledge MD, Cook GJR, Chua S, Du Y, Hafeez S, Murray I, Padhani AR, Staffurth J, Tree A, Stidwill H, Finch J, Curcean A, Chatfield P, Perry S, Koh DM, Hall E. Parker C, et al. JNCI Cancer Spectr. 2023 Oct 31;7(6):pkad077. doi: 10.1093/jncics/pkad077. JNCI Cancer Spectr. 2023. PMID: 37788117 Free PMC article. Clinical Trial.
An essential goal within reach: attaining diversity, equity, and inclusion for the Journal of the National Cancer Institute journals.
Yabroff KR, Boehm AL, Nogueira LM, Sherman M, Bradley CJ, Shih YT, Keating NL, Gomez SL, Banegas MP, Ambs S, Hershman DL, Yu JB, Riaz N, Stockler MR, Chen RC, Franco EL. Yabroff KR, et al. JNCI Cancer Spectr. 2023 Aug 31;7(5):pkad063. doi: 10.1093/jncics/pkad063. JNCI Cancer Spectr. 2023. PMID: 37806772 Free PMC article. No abstract available.
Adjuvant chemotherapy benefit according to T and N stage in small bowel adenocarcinoma: a large retrospective multicenter study.
Zaanan A, Henriques J, Turpin A, Manfredi S, Coriat R, Terrebonne E, Legoux JL, Walter T, Locher C, Dubreuil O, Pernot S, Vernet C, Bouché O, Hautefeuille V, Gagniere J, Lecomte T, Tougeron D, Grainville T, Vernerey D, Afchain P, Aparicio T. Zaanan A, et al. JNCI Cancer Spectr. 2023 Aug 31;7(5):pkad064. doi: 10.1093/jncics/pkad064. JNCI Cancer Spectr. 2023. PMID: 37774004 Free PMC article.
Ki67 and breast cancer mortality in women with invasive breast cancer.
Probert J, Dodwell D, Broggio J, Charman J, Dowsett M, Kerr A, McGale P, Taylor C, Darby SC, Mannu GS. Probert J, et al. JNCI Cancer Spectr. 2023 Aug 31;7(5):pkad054. doi: 10.1093/jncics/pkad054. JNCI Cancer Spectr. 2023. PMID: 37567612 Free PMC article.
Use of the Decipher genomic classifier among men with prostate cancer in the United States.
Zaorsky NG, Proudfoot JA, Jia AY, Zuhour R, Vince R Jr, Liu Y, Zhao X, Hu J, Schussler NC, Stevens JL, Bentler S, Cress RD, Doherty JA, Durbin EB, Gershman S, Cheng I, Gonsalves L, Hernandez BY, Liu L, Morawski BM, Schymura M, Schwartz SM, Ward KC, Wiggins C, Wu XC, Shoag JE, Ponsky L, Dal Pra A, Schaeffer EM, Ross AE, Sun Y, Davicioni E, Petkov V, Spratt DE. Zaorsky NG, et al. JNCI Cancer Spectr. 2023 Aug 31;7(5):pkad052. doi: 10.1093/jncics/pkad052. JNCI Cancer Spectr. 2023. PMID: 37525535 Free PMC article.
Quantifying the impact of the COVID-19 pandemic on cancer center clinical trial operations.
George TJ, Lin TL, Adrales Bentz T, Grant S, Houston CM, Nashawati MA, Pappu B, Peck H, Zafirovski A, Kerstann K, LoRusso P, Schnatterly A, Hofacker J, Cameron K, Honeycutt H, Werner TL. George TJ, et al. JNCI Cancer Spectr. 2023 Jul 3;7(4):pkad048. doi: 10.1093/jncics/pkad048. JNCI Cancer Spectr. 2023. PMID: 37467065 Free PMC article.
Career disruption and limitation of financial earnings due to cancer.
Mudaranthakam DP, Hughes D, Johnson P, Mason T, Nollen N, Wick J, Welch DR, Calhoun E. Mudaranthakam DP, et al. JNCI Cancer Spectr. 2023 Jul 3;7(4):pkad044. doi: 10.1093/jncics/pkad044. JNCI Cancer Spectr. 2023. PMID: 37326961 Free PMC article.
Reranking cancer mortality using years of life lost.
Radkiewicz C, Andersson TM, Lagergren J. Radkiewicz C, et al. JNCI Cancer Spectr. 2023 May 2;7(3):pkad038. doi: 10.1093/jncics/pkad038. JNCI Cancer Spectr. 2023. PMID: 37252821 Free PMC article.
Allostatic load and cardiovascular outcomes in males with prostate cancer.
Stabellini N, Cullen J, Bittencourt MS, Moore JX, Cao L, Weintraub NL, Harris RA, Wang X, Datta B, Coughlin SS, Garcia J, Shanahan J, Hamerschlak N, Waite K, Fillmore NR, Terris M, Montero AJ, Barnholtz-Sloan JS, Guha A. Stabellini N, et al. JNCI Cancer Spectr. 2023 Mar 1;7(2):pkad005. doi: 10.1093/jncics/pkad005. JNCI Cancer Spectr. 2023. PMID: 36752520 Free PMC article.
Expanding access to early phase trials: the CATCH-UP.2020 experience.
Baranda JC, Diaz FJ, Rubinstein L, Shields AF, Dayyani F, Mehta A, Mehnert JM, Trent J, Mabaera R, Mooney M, Moscow JA, Doroshow J, Waters B, Ivy P, Gore SD, Thomas A. Baranda JC, et al. JNCI Cancer Spectr. 2023 Jan 3;7(1):pkac087. doi: 10.1093/jncics/pkac087. JNCI Cancer Spectr. 2023. PMID: 36525371 Free PMC article.
Multicancer early detection tests: where are we?
Loomans-Kropp HA. Loomans-Kropp HA. JNCI Cancer Spectr. 2023 Jan 3;7(1):pkac084. doi: 10.1093/jncics/pkac084. JNCI Cancer Spectr. 2023. PMID: 36453871 Free PMC article. No abstract available.
Prediction of tissue-of-origin of early stage cancers using serum miRNomes.
Matsuzaki J, Kato K, Oono K, Tsuchiya N, Sudo K, Shimomura A, Tamura K, Shiino S, Kinoshita T, Daiko H, Wada T, Katai H, Ochiai H, Kanemitsu Y, Takamaru H, Abe S, Saito Y, Boku N, Kondo S, Ueno H, Okusaka T, Shimada K, Ohe Y, Asakura K, Yoshida Y, Watanabe SI, Asano N, Kawai A, Ohno M, Narita Y, Ishikawa M, Kato T, Fujimoto H, Niida S, Sakamoto H, Takizawa S, Akiba T, Okanohara D, Shiraishi K, Kohno T, Takeshita F, Nakagama H, Ota N, Ochiya T; Project Team for Development and Diagnostic Technology for Detection of miRNA in Body Fluids. Matsuzaki J, et al. JNCI Cancer Spectr. 2023 Jan 3;7(1):pkac080. doi: 10.1093/jncics/pkac080. JNCI Cancer Spectr. 2023. PMID: 36426871 Free PMC article.
Physical Activity and Health-Related Quality of Life in Women With Breast Cancer: A Meta-Analysis.
Aune D, Markozannes G, Abar L, Balducci K, Cariolou M, Nanu N, Vieira R, Anifowoshe YO, Greenwood DC, Clinton SK, Giovannucci EL, Gunter MJ, Jackson A, Kampman E, Lund V, McTiernan A, Riboli E, Allen K, Brockton NT, Croker H, Katsikioti D, McGinley-Gieser D, Mitrou P, Wiseman M, Velikova G, Demark-Wahnefried W, Norat T, Tsilidis KK, Chan DSM. Aune D, et al. JNCI Cancer Spectr. 2022 Nov 1;6(6):pkac072. doi: 10.1093/jncics/pkac072. JNCI Cancer Spectr. 2022. PMID: 36474321 Free PMC article.
Impact of Clinical Data Veracity on Cancer Genomic Research.
Mehta S, Wright D, Black MA, Merrie A, Anjomshoaa A, Munro F, Reeve A, McCall J, Print C. Mehta S, et al. JNCI Cancer Spectr. 2022 Nov 1;6(6):pkac070. doi: 10.1093/jncics/pkac070. JNCI Cancer Spectr. 2022. PMID: 36255250 Free PMC article.
Body mass index trajectories, weight gain and risks of liver and biliary tract cancers.
Yang W, Zeng X, Petrick JL, Danford CJ, Florio AA, Lu B, Nan H, Ma J, Wang L, Zeng H, Sudenga SL, Campbell PT, Giovannucci E, McGlynn KA, Zhang X. Yang W, et al. JNCI Cancer Spectr. 2022 Aug 12;6(4):pkac056. doi: 10.1093/jncics/pkac056. Online ahead of print. JNCI Cancer Spectr. 2022. PMID: 35960613 Free PMC article.
The Increasing Importance of Rigorous Real-World Evidence.
Yang DD, Nguyen PL. Yang DD, et al. JNCI Cancer Spectr. 2022 Aug 10;6(4):pkac051. doi: 10.1093/jncics/pkac051. Online ahead of print. JNCI Cancer Spectr. 2022. PMID: 35947686 Free PMC article. No abstract available.
Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial.
James ND, Ingleby FC, Clarke NW, Amos CL, Attard G, Brawley CD, Chowdhury S, Cross W, Dearnaley DP, Gilbert DC, Gillessen S, Jones RJ, Langley RE, Macnair A, Malik ZI, Mason MD, Matheson DJ, Millman R, Parker CC, Rush HL, Russell JM, Au C, Ritchie AWS, Mestre RP, Ahmed I, Birtle AJ, Brock SJ, Das P, Ford VA, Gray EK, Hughes RJ, Manetta CB, McLaren DB, Nikapota AD, O'Sullivan JM, Perna C, Peedell C, Protheroe AS, Sundar S, Tanguay JS, Tolan SP, Wagstaff J, Wallace JB, Wylie JP, Zarkar A, Parmar MKB, Sydes MR. James ND, et al. JNCI Cancer Spectr. 2022 Jul 1;6(4):pkac043. doi: 10.1093/jncics/pkac043. JNCI Cancer Spectr. 2022. PMID: 35877084 Free PMC article. Clinical Trial.
Prioritizing Measures That Matter Within a Person-Centered Oncology Learning Health System.
Van Citters AD, Kennedy AM, Kirkland KB, Dragnev KH, Leach SD, Buus-Frank ME, Malcolm EF, Holthoff MM, Holmes AB, Nelson EC, Reeves SA, Tosteson ANA; Promise Partnership Delphi Panel. Van Citters AD, et al. JNCI Cancer Spectr. 2022 May 2;6(3):pkac037. doi: 10.1093/jncics/pkac037. JNCI Cancer Spectr. 2022. PMID: 35736219 Free PMC article.
The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer.
Shah NJ, Patel VG, Zhong X, Pina L, Hawley JE, Lin E, Gartrell BA, Febles VA, Wise DR, Qin Q, Mellgard G, Joshi H, Nauseef JT, Green DA, Vlachostergios PJ, Kwon DH, Huang F, Liaw B, Tagawa S, Kantoff P, Morris MJ, Oh WK. Shah NJ, et al. JNCI Cancer Spectr. 2022 May 2;6(3):pkac035. doi: 10.1093/jncics/pkac035. JNCI Cancer Spectr. 2022. PMID: 35657341 Free PMC article.
Time-Restricted Feeding Studies and Possible Human Benefit.
Boyd P, O'Connor SG, Heckman-Stoddard BM, Sauter ER. Boyd P, et al. JNCI Cancer Spectr. 2022 May 2;6(3):pkac032. doi: 10.1093/jncics/pkac032. JNCI Cancer Spectr. 2022. PMID: 35657339 Free PMC article.
Mammographic Density Decline, Tamoxifen Response, and Prognosis by Molecular Characteristics of Estrogen Receptor-Positive Breast Cancer.
Abubakar M, Mullooly M, Nyante S, Pfeiffer RM, Aiello Bowles EJ, Cora R, Bodelon C, Butler E, Butcher D, Sternberg L, Troester MA, Weinmann S, Sherman M, Glass AG, Berrington de Gonzalez A, Gierach GL. Abubakar M, et al. JNCI Cancer Spectr. 2022 May 2;6(3):pkac028. doi: 10.1093/jncics/pkac028. JNCI Cancer Spectr. 2022. PMID: 35583138 Free PMC article.
642 results